UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...

Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically amplifies the T-cell response to vaccines - an advance that could lead to far more ...

U.S. Personalized Cancer Vaccine Market was valued at USD 76.8 million in 2025 and is expected to reach USD 2.743 billion by 2035 owing to the presence of most prominent personalized vaccine ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Subscribe ...

Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat ...

India faces a stark reality with a quarter of global cervical cancer deaths, a preventable tragedy. Dr. Sonia Mathai ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

Just five months after giving birth to our third (and final) child in 2015, my wife experienced something odd: Her smile became crooked. Appearance didn’t matter, of course. This was just different ...